USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark BIOXELL was filed as Word mark on 06/28/2002 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - NO STATEMENT OF USE FILED".
| Trademark form | Word mark |
| File reference | 78140004 |
| Application date | June 28, 2002 |
| Publication date | November 24, 2009 |
Trademark owner
Via Olgettina 58
20132 Milano
IT
20132 Milano
IT
Trademark representatives
goods and services
5
(Based on Intent to Use) (Based on 44(e)) All purpose disinfectants and pharmaceutical preparations, namely, antiulcerants, antispasmodics, anticholinergics and gastroprokinetics, digestives, including digestive enzymes, anti-diabetics, vitamins, mineral supplements, systemic anabolics, antifibrinolytics, antidotes to anti-coagulants, blood coagulation inhibitors, anti-anaemics, hypolipidaemics, anti-atheromas, fibrinolytics, hematological agents, anti-angiogenesis agents, cardiovascular pharmaceuticals, antihypertensives, anti-ischaemics, dermatological drugs, hair growth agents, erectile dysfunction drugs, antibiotics, sulphonamides and antiviral drugs, anti-parasite agents, genito-urinary system and sex hormones, reproductive system drugs, systemic hormonal preparations, hormones, systemic corticosteroids, thyroid therapeutics, general anti-infective drugs, cytostatics, muscular-skeletal system drugs, uterine mobility drugs, renal function drugs, topical anti-rheumatics, muscle relaxants, anti-gout preparations, anti-inflammatory agents, therapeutic antibodies, immunomodulators, immunostimulators, inimunosuppressants, anti-sepsis and septic shock agents, analgesics, pain control drugs, central nervous system drugs, respiratory system drugs, throat preparations, bronchodilators and anti-asthma preparations, cough and cold treatment preparations, systemic antihistamines, oplitalmological drugs, otological drugs, allergens, diagnostic proteins, diagnostic antibodies, diagnostic nucleic acids, contrast agents, oncological drugs, anti-tumor agents, and anti-proliferative drugs
42
(Based on Intent to Use) Research and development services in pharmaceutical and biotechnological field
ID: 1378140004